C12N 2501/70
Enzymes
C12N2501/70 (Enzymes) appears on 1,211 US grants and 2,898 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,211
- Published applications
- 2,898
- Assignees
- 1,150
- Inventors
- 5,214
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 14 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 9 | 3 |
| 2002 | 11 | 19 |
| 2003 | 9 | 23 |
| 2004 | 5 | 19 |
| 2005 | 9 | 23 |
| 2006 | 5 | 23 |
| 2007 | 5 | 29 |
| 2008 | 4 | 22 |
| 2009 | 8 | 41 |
| 2010 | 12 | 63 |
| 2011 | 14 | 55 |
| 2012 | 17 | 56 |
| 2013 | 21 | 72 |
| 2014 | 35 | 67 |
| 2015 | 59 | 106 |
| 2016 | 68 | 158 |
| 2017 | 51 | 159 |
| 2018 | 84 | 167 |
| 2019 | 109 | 192 |
| 2020 | 89 | 177 |
| 2021 | 88 | 230 |
| 2022 | 82 | 224 |
| 2023 | 85 | 225 |
| 2024 | 104 | 279 |
| 2025 | 102 | 265 |
| 2026 | 76 | 201 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Methods of activating cells via PTP 1B inhibition29 Sep 2026US 12,746,285 B2Monash University
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Method for preserving fermentation broth of engineered strain of D-psicose-3-epimerase22 Sep 2026US 12,742,150 B2Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd.
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Small Molecule Based Method Of Modifying T Cells8 Oct 2026US 2026/0308520 A1Agency for Science, Technology and Research
- Method for producing high-titer viral vector8 Oct 2026US 2026/0308534 A1Kaneka Corporation
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
Most cited
By later US patents
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987
- Methods of repairing connective tissues151US 5,916,557 AInternational Technology Management Associates, Ltd. · 1999
- Therapy and diagnosis of conditions related to telomere length and/or telomerase activity143US 5,489,508 AUniversity of Texas System Board of Regents · 1996
- Transplants for myocardial scars141US 6,099,832 AGenzyme Corporation · 2000
- Composition containing autologous thrombin blood fraction for use in a medical procedure136US 5,795,571 ABristol-Myers Squibb Company · 1998